UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018268 |
|---|---|
| Receipt number | R000021144 |
| Scientific Title | Clinical investigation of change of bone-related marker between denosumab and zoledronic acid in patients with treatment-naive,bone-metastasis prostate cancer:prospective, multiinstitutional,cohort study |
| Date of disclosure of the study information | 2015/12/01 |
| Last modified on | 2015/12/09 20:18:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/10 16:03:22 | ||
| 2 | Update | 2015/07/18 19:01:56 | Public title Public title |
|
| 3 | Update | 2015/07/18 19:06:59 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Name of person sending information Co-sponsor Co-sponsor Date of disclosure of the study information |
|
| 4 | Update | 2015/07/18 19:08:18 | Date of protocol fixation Anticipated trial start date Last follow-up date |
|
| 5 | Update | 2015/07/18 19:11:22 | Blinding |
|
| 6 | Update | 2015/07/18 19:12:31 | Key exclusion criteria |
|
| 7 | Update | 2015/07/18 19:15:37 | Public title |
|
| 8 | Update | 2015/07/21 14:55:39 | Public title Public title Acronym Acronym |
|
| 9 | Update | 2015/07/21 14:57:07 | Condition Condition Key secondary outcomes Key secondary outcomes |
|
| 10 | Update | 2015/07/21 14:59:32 | Key exclusion criteria Key exclusion criteria |
|
| 11 | Update | 2015/07/22 08:01:07 | Date of disclosure of the study information |
|
| 12 | Update | 2015/07/22 08:02:10 | Date of protocol fixation Anticipated trial start date Last follow-up date |
|
| 13 | Update | 2015/07/22 17:01:14 | Acronym |
|
| 14 | Update | 2015/08/04 15:56:00 | Public title Public title |
|
| 15 | Update | 2015/08/04 15:59:32 | Narrative objectives1 Narrative objectives1 |
|
| 16 | Update | 2015/08/04 16:00:25 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 17 | Update | 2015/09/07 10:20:04 | Date of disclosure of the study information |
|
| 18 | Update | 2015/09/07 10:20:30 | Anticipated trial start date Last follow-up date |
|
| 19 | Update | 2015/09/29 09:51:05 | Public title Public title Acronym Acronym |
|
| 20 | Update | 2015/09/29 09:55:48 | Narrative objectives1 Narrative objectives1 Basic objectives2 Trial characteristics_1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 21 | Update | 2015/09/29 09:59:27 | Study type Basic design Randomization Randomization unit Blinding Control Concealment No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Target sample size |
|
| 22 | Update | 2015/09/29 10:00:44 | Date of disclosure of the study information |
|
| 23 | Update | 2015/10/10 10:46:31 | Public title |
|
| 24 | Update | 2015/10/10 10:49:58 | Co-sponsor Co-sponsor |
|
| 25 | Update | 2015/10/19 11:25:11 | Public title |
|
| 26 | Update | 2015/10/19 11:28:35 | Condition Condition Classification by specialty Narrative objectives1 Narrative objectives1 Primary outcomes |
|
| 27 | Update | 2015/10/19 11:33:14 | Key inclusion criteria Key inclusion criteria |
|
| 28 | Update | 2015/10/19 12:18:18 | Date of protocol fixation Anticipated trial start date Last follow-up date Other related information Other related information |
|
| 29 | Update | 2015/12/06 10:38:51 | Recruitment status |
|
| 30 | Update | 2015/12/09 20:18:51 | Other related information Other related information |
